Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin

Annals of Surgery

Volumn 224, Issue 3, 1996, Pages 350-357

  Grosfeld, Jay L ^a,d   Chaet, Mark ^a   Molinari, Francine ^b   Engle, William ^c   Engum, Scott A ^a   West, Karen W ^a   Rescorla, Frederick J ^b   Scherer III, L R ^c  

^a Section of Cardiothoracic Surgery   (United States)

^b Division of Neonatology   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN;

CONFERENCE PAPER; FEMALE; HUMAN; INFANT; INFANT MORTALITY; INTESTINE PERFORATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT PLANNING; VERY LOW BIRTH WEIGHT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DUCTUS ARTERIOSUS, PATENT; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; MALE; RISK FACTORS;

EID: 0029792569     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199609000-00011     Document Type: Conference Paper

References (30)

1. Relier MD, LorenzJM, Kotagal UR, ctal. Hemodynamically significant PDA: an echocardiographic and clinical assessment of incidence, natural history, and outcome in very low birthweight infants maintained in negative fluid balance. Pediatr Cardiol 1985; 6:17-24.
2. Mahony L, Carnero V, Brett C et al. Prophylactic indomethacin therapy for patent ductus arteriosus in very low birthweight infants. N Engl J Med 1982;306:506-510.
3. Gersony WM, Peckham GJ, Ellison RCet al. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983; 102:895-906.
4. Rajadurai VS, Yu VYH. Intravenous indomethacin therapy in preterm nconatcs with patent ductus arteriosus. J Pediatr Child Health 1991; 27:370-375.
5. Nagaraj US, Amarjit SS, Cook LN, et al. Gastrointestinal perfora-lion following indomethacin treatment in very low birthweight infants. J PediatrSurg 1981; 16:1003-1007.
6. Vanhaesebrouck P, Thiery M, Leroy JG, et al. Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethaein. J Pediatr 1988; 113:738-743.
7. Kühl G, Wille L, Bolkenius M, Seyberth HW. Intestinal perforation associated with indomethacin treatment in premature infants. Eur J Pediatr 1985; 143:213-216.
8. Alpan G, Eyal F, Vinograd I, et al. Localized intestinal perforations after enterai administration of indomethacin in premature infants. J Pediatr 1985; 106:277-281.
9. Gray PH, Pemberton PJ. Gastric perforation associated with indomethacin therapy in a preterm infant. Aust Pediatr J 1980; 16:65-66.
10. Meyer CL, Payne NR, Roback SA. Spontaneous isolated perforation in neonates with birth weight < 1,000 g not associated with necrotizingenterocolitis. J PediatrSurg 1991;21:714-717.
11. Buchheit JQ, Stewart DL. Clinical comparison of localized intestinal perforation and necrotizing enterocolitis in neonates. Pediatrics 1994; 93:32-36.
12. Kosloske AM. Indications for operation in necrotizing enterocolitis revisited. J PediatrSurg 1994; 29:663-666.
13. Grosfeld JL, Cheu H, Schlatter M. Changing trends in necrotizing enetrocolitis:experience with 302 cases in two decades. Ann Surg 1991; 214:300-307.
14. Grosfeld JL, Kamman K, Gross K, et al. Comparative eflfect of indomethacin, prostaglandin-El, and ibuprofen on bowel ischemia. J PediatrSurg 1983; 18:738-742.
15. Rowe MI. Physiology of infections. In: Rowe MI, O'Neill JA, Grosfeld JL, et al., eds. Essentials of Pédiatrie Surgery. St. Louis, MO: Mosby-Year Book Publishers; 1995:94-105.
16. Grosfeld JL, Chaet M, Molinari F, et al. Gastrointestinal perforation and peritonitis in infants and children: experience with 179 cases. Surgery 1996 (in press).
17. Trus T, Winthrop AL, Pipe S, et al. Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g. J Pediatr Surg 1993; 28:1137-1139.
18. Mavroudis C, Cook LN, Fleischaker JW, et al. Management of patent ductus arteriosus in the premature infant: indomethacin versus ligation. Ann Thorac Surg 1983; 36:561-566.
19. Robie DK, Waltrip T, Garcia-Prats JA, et al. Is surgical ligation of a patent ductus arteriosus the preferred initial approach in the ELBW neonate? J PediatrSurg 1996 (in press).
20. Halac E, Halac J, Bègue EF, et al. Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial. J Pediatr 1990; 117:132-138.
21. Gillan E, Christensen R, Suen Y, et al. A randomized placebocontrolled trial of recombinant human granulocyte colony stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia. Blood 1994:84:1427-1433.
22. Gennari R, Alexander WJ, Gianotti L, et al. Granulocyte macrophage colony stimulating factor improves survival in two models of gut derived sepsis by improving gut barrier function and modulating bacterial clearance. Ann Surg 1994; 220:68-76.
23. Eibl M, Wolf HM, Furnkranz H, Rosenkranz A. Prevention of necrotizing enterocolitis in low birth weight infants by IgA-IgG feeding. N EnglJMed 1988:319:1-7.
24. Maxson RT, Jackson RJ, Smith SD. The protective role of enterai IgA supplementation in neonatal gut origin sepsis. J Pediatr Surg 1995:30:231-234.
25. Williams DA. Intcrleukin-11 : a multifactorial growth fac-tor derived from the hcmatopoietic microcnvironment. Blood 1994:83:2030-2037.
26. Liu Q, Schinde DT, Yang ZX, et al.Trophic effects of interleukin11 in rats with experimental short bowel syndrome. J Pediatr Surg 1996 (in press).
27. Doerschuk CM, Orazi A, Williams DA. A bone marrow stromal derived growth factor IL-11 stimulates recovery' of small intestinal mucosa after cytoablative therapy. Blood 1994; 83:33-37.
28. Schindel DT, Maze R, Liu Q, et al. Intcrleukin-11 improves survival and reduces bacterial translocation and marrow suppression in burned mice. J Pediatr Surg (in press).
29. Vavarigou A, Bardin CL, Beharry K, et al. Early ibuprofen administration to prevent patent duct us arteriosus in premature newborn infants. JAMA 1966:275:539-544.
30. Coceani F, White E, Bodach E, Olley PM. Age dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen. Can J Physiol Pharacol 1979:57:825-831.